Identification of a shine-through artifact in the trachea with 124I PET/CT

Journal of Nuclear Medicine

Volumn 50, Issue 6, 2009, Pages 909-911

  Abdul Fatah, Sakar B ^a   Zamburlini, Mariangela ^a   Halders, Servé G E A ^a   Brans, Boudewijn ^a   Teule, Gerrit J J ^a   Kemerink, Gerrit J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

124I PET CT; High energy positrons; Radioiodine; Thyroid disease

Indexed keywords

FLUORINE 18; GALLIUM 68; IODINE 124;

ARTICLE; ARTIFACT; ARTIFACT REDUCTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; EARLY DIAGNOSIS; HUMAN; HUMAN TISSUE; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHINE THROUGH PHENOMENON; THYROID CANCER; TRACHEA INJURY;

ARTIFACTS; HUMANS; IODINE RADIOISOTOPES; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TRACHEA;

EID: 66649102763     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.060442     Document Type: Article

References (5)

1. Freudenberg LS, Antoch G, Frilling A, et al. Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET. Eur J Nucl Med Mol Imaging. 2008;35:950-957.
2. 124I-PET in patients with differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2008;35:958-965.
3. 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer. J Nucl Med. 2008;49:1017-1023.
4. Blanco A. Positron range effects on the spatial resolution of RPC-PET. IEEE Nucl Sci Symp Conf Rec. 2006;4:2570-2573.
5. Jentzen W, Weise R, Kupferschläger J, et al. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET/ (CT) systems. Eur J Nucl Med Mol Imaging. 2008;35:611-623.